| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | 17.1× | −1.7× | |
| Price / Book | 3.2× | 2.0× | |
| Price / Sales | 7.2× | 3.9× | |
| Price / Free cash flow | 22.0× | −1.6× | |
| EV / EBITDA | 11.7× | −1.2× | |
| Earnings yield | 5.8% | −14.6% | |
| Free cash flow yield | 4.6% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,240.34 | −1.33% | $1.17T | 57.3× | 77.8% | +16.7% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $253.79 | −0.69% | $611.61B | 23.0× | 32.9% | +33.7% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $282.68 | −0.96% | $499.53B | 119.3× | −129.2% | +26.2% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $406.88 | +1.36% | $365.21B | 29.9× | 12.8% | +11.2% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $143.63 | −1.59% | $354.36B | 19.7× | 34.7% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $150.20 | −0.28% | $277.86B | 19.8× | 30.5% | +15.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $163.95 | −0.88% | $254.27B | 25.0× | 21.1% | −2.2% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $679.38 | −1.54% | $251.2B | 37.9× | 12.6% | +30.7% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $424.94 | −1.75% | $229.74B | 30.3× | 89.1% | +45.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $153.07 | −2.00% | $189.8B | 22.8× | 37.5% | +32.0% |
